This is a preprint.
Dynamic Prioritization of COVID-19 Vaccines When Social Distancing is Limited for Essential Workers
- PMID: 32995816
- PMCID: PMC7523157
- DOI: 10.1101/2020.09.22.20199174
Dynamic Prioritization of COVID-19 Vaccines When Social Distancing is Limited for Essential Workers
Update in
-
Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers.Proc Natl Acad Sci U S A. 2021 Apr 20;118(16):e2025786118. doi: 10.1073/pnas.2025786118. Proc Natl Acad Sci U S A. 2021. PMID: 33811185 Free PMC article.
Abstract
COVID-19 vaccines have been authorized in multiple countries and more are under rapid development. Careful design of a vaccine prioritization strategy across socio-demographic groups is a crucial public policy challenge given that (1) vaccine supply will be constrained for the first several months of the vaccination campaign, (2) there are stark differences in transmission and severity of impacts from SARS-CoV-2 across groups, and (3) SARS-CoV-2 differs markedly from previous pandemic viruses. We assess the optimal allocation of a limited vaccine supply in the U.S. across groups differentiated by age and also essential worker status, which constrains opportunities for social distancing. We model transmission dynamics using a compartmental model parameterized to capture current understanding of the epidemiological characteristics of COVID-19, including key sources of group heterogeneity (susceptibility, severity, and contact rates). We investigate three alternative policy objectives (minimizing infections, years of life lost, or deaths) and model a dynamic strategy that evolves with the population epidemiological status. We find that this temporal flexibility contributes substantially to public health goals. Older essential workers are typically targeted first. However, depending on the objective, younger essential workers are prioritized to control spread or seniors to directly control mortality. When the objective is minimizing deaths, relative to an untargeted approach, prioritization averts deaths on a range between 20,000 (when non-pharmaceutical interventions are strong) and 300,000 (when these interventions are weak). We illustrate how optimal prioritization is sensitive to several factors, most notably vaccine effectiveness and supply, rate of transmission, and the magnitude of initial infections.
Figures
References
-
- Corey L, Mascola JR, Fauci AS, Collins FS, A strategic approach to COVID-19 vaccine R&D. Science 368, 948–950 (2020). - PubMed
-
- Florko N, First Covid-19 vaccines to arrive in states Monday, marking a pivotal moment in the pandemic response (STAT, https://www.statnews.com/2020/12/12/shipments-of-first-authorized-covid-...) (2020).
-
- Emanuel E, et al., Fair allocation of scarce medical resources in the time of Covid-19. The New England Journal of Medicine 382, 2049–2055 (2020). - PubMed
-
- Toner E, Barnill A, Krubiner C, et al., Interim framework for COVID-19 vaccine allocation and distribution in the United States (Baltimore, MD: Johns Hopkins Center for Health Security, https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/...) (2020).
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous